OSLM
Outcome Studies
in Laboratory Medicine
guest
👤
Learn more about this platform
c
Categories
p
Projects
Highlighted
Trial protocol
Study Design
RCT
Cluster RCT
Observational
Model
Meta-analysis
Review
Guideline
Outcomes
Change patient management
Clinical outcomes
Economics
Operational efficiencies
Patient-centeredness
Safety
Guide Policy Making
Other
Uncategorized
Antibiotic Guidance
ACT Guided Heparinization
Cancer
COVID-19
Cardiovascular Disease
Diabetes
HIV POCT
Inflammatory Bowel Disease
Liver Disease
Kidney Disease
Newborn Screening
MALDI-TOF MS For Microorganism Identification
Preeclampsia
Pharmacogenetic and Pharmacogenomics
Therapeutic drug monitoring
Viscoelastic Testing
Please contact us for any suggestions
Zhen Zhao
Smeralda Skenderaj
Search
Search
Categories:
Economics
181 Publications
found
Assessment of the Potential Impact and Cost-effectiveness of Self-Testing for HIV in Low-Income Countries.
b
The Journal of infectious diseases
August 15, 2015
p
HIV POCT
c
Economics
Model
Cost-Effectiveness Analysis of a National Newborn Screening Program for Biotinidase Deficiency.
b
Pediatrics
August 1, 2015
p
Newborn Screening
c
Economics
Model
High-sensitivity troponin assays for the early rule-out or diagnosis of acute myocardial infarction in people with acute chest pain: a systematic review and cost-effectiveness analysis.
b
Health technology assessment (Winchester, England)
June 1, 2015
p
Cardiovascular Disease
c
Economics
Model
Systematic neonatal screening for severe combined immunodeficiency and severe T-cell lymphopenia: Analysis of cost-effectiveness based on French real field data.
b
The Journal of allergy and clinical immunology
June 1, 2015
p
Newborn Screening
c
Economics
Observational
Outcome and economic implications of proteomic test-guided second- or third-line treatment for advanced non-small cell lung cancer: extended analysis of the PROSE trial.
b
Lung cancer (Amsterdam, Netherlands)
May 1, 2015
p
Cancer
c
Clinical outcomes
Economics
Model
Cost-effectiveness of multiplexed predictive biomarker screening in non-small-cell lung cancer.
b
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
April 1, 2015
p
Cancer
c
Economics
Model
Cost-effectiveness of newborn screening for cystic fibrosis determined with real-life data.
b
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
March 1, 2015
p
Newborn Screening
c
Economics
Model
Personalised treatment using serum drug levels of adalimumab in patients with rheumatoid arthritis: an evaluation of costs and effects.
b
Annals of the rheumatic diseases
February 1, 2015
p
Therapeutic drug monitoring
c
Economics
Model
Showing Value in Newborn Screening: Challenges in Quantifying the Effectiveness and Cost-Effectiveness of Early Detection of Phenylketonuria and Cystic Fibrosis.
b
Healthcare (Basel, Switzerland)
January 1, 2015
p
Newborn Screening
c
Economics
Model
Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation.
b
Health technology assessment (Winchester, England)
January 1, 2015
p
Liver Disease
c
Economics
Review
Previous Page
1
…
14
15
16
17
18
19
Next Page
